Subscribe To
CTMX / CytomX's Breast Cancer Candidate Meets Primary Goal Of Objective Response Rate
CTMX News
By GlobeNewsWire
September 5, 2023
CytomX Therapeutics to Present at Upcoming September Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activ more_horizontal
By Zacks Investment Research
August 25, 2023
CytomX Therapeutics (CTMX) Loses -13.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for CytomX Therapeutics (CTMX) as it is technically in oversold territory now. In addition to this tec more_horizontal
By Seeking Alpha
August 8, 2023
CytomX Therapeutics, Inc. (CTMX) Q2 2023 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q2 2023 Results Conference Call August 8, 2023 5:00 PM ET Company Participants Chris Ogden - Senior Vice Pres more_horizontal
By Zacks Investment Research
August 8, 2023
CytomX Therapeutics (CTMX) Reports Q2 Loss, Tops Revenue Estimates
CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to more_horizontal
By GlobeNewsWire
June 1, 2023
CytomX Therapeutics to Present at the Jefferies Healthcare Conference
SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activa more_horizontal
By Seeking Alpha
May 9, 2023
CytomX Therapeutics, Inc. (CTMX) Q1 2023 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q1 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Chris Ogden - SVP, Finance & Acco more_horizontal
By Zacks Investment Research
May 9, 2023
CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates
CytomX Therapeutics (CTMX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to more_horizontal
By Seeking Alpha
March 27, 2023
CytomX Therapeutics, Inc. (CTMX) Q4 2022 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q4 2022 Earnings Conference Call March 27, 2023 5:00 PM ET Company Participants Chris Ogden - SVP of Finance more_horizontal